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Abstract
TGFβ/BMP signaling pathways are essential for normal development of neural crest cells (NCCs). Smad4 encodes the only common Smad
protein in mammals, which is a critical nuclear mediator of TGFβ/BMP signaling. In this work, we sought to investigate the roles of Smad4 for
development of NCCs. To overcome the early embryonic lethality of Smad4 null mice, we specifically disrupted Smad4 in NCCs using a Cre/loxP
system. The mutant mice died at mid-gestation with defects in facial primordia, pharyngeal arches, outflow tract and cardiac ventricles. Further
examination revealed that mutant embryos displayed severe molecular defects starting from E9.5. Expression of multiple genes, includingMsx1, 2,
Ap-2α, Pax3, and Sox9, which play critical roles for NCC development, was downregulated by NCC disruption of Smad4. Moreover, increased cell
death was observed in pharyngeal arches from E10.5. However, the cell proliferation rate in these areas was not substantially altered. Taken together,
these findings provide compelling genetic evidence that Smad4-mediated activities of TGFβ/BMP signals are essential for appropriate NCC
development.
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Neural crest cells (NCCs) are a group multi-potent, migra-
tory cells that are generated from the interface of dorsal ecto-
derm and neural tube along the neuraxis. After generation and
specification, NCCs delaminate from the neural fold and mi-
grate ventral-laterally to participate in organogenesis and cons-
titute essential elements of a number of tissues. Their migration
is orchestrated into separately aggregated streams. NCCs in the
anterior neural tube (forebrain, midbrain, and hindbrain), also
known as cranial NCCs, mainly migrate to the regions of
presumptive facial primordia, drive the outgrowth of the facial
primordia and later form NCC derivatives in the craniofacialAbbreviations: NC, neural crest; NCCs, neural crest cells; OFT, outflow
track; PA, pharyngeal arch; PAA, pharyngeal arch artery.
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doi:10.1016/j.ydbio.2008.02.006region (Creuzet et al., 2005; Graham et al., 2004; Helms et al.,
2005; Osumi-Yamashita et al., 1994). Some NCCs from the
caudal hindbrain also participate in the formation of the enteric
nervous system in the gut (Burns, 2005; Young et al., 2004). In
addition, a group of NCCs located caudal to the otic vesicle
(otic vesicle to the third somite) migrates to the pharyngeal
region and the outflow tract (OFT) of embryonic hearts through
pharyngeal arches (PAs) 3, 4 and 6, where they contribute to
cardiovascular development and are thus known as cardiac
NCCs (Jiang et al., 2000). These cells are essential participants
in the formation of the OFT septum, and hence, the division of
pulmonary and aortic arteries (Jiang et al., 2000; Kirby and
Waldo, 1995). At the trunk level, NCCs give rise to structures
such as the dorsal root ganglia and sympathetic ganglia
(Graham et al., 2004).
NCCs play essential roles during craniofacial and cardiovas-
cular development in vertebrates. Experimental ablation of
NCCs in animal models inevitably leads to a spectrum of cra-
niofacial and cardiovascular anomalies (Bockman et al., 1990;
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of craniofacial elements and some segments of large vessels are
closely related, and all are derived from a set of temporary
embryonic apparatus, the PAs. In mammals, five pairs of
bilaterally symmetric PAs (PA1, 2, 3, 4 and 6) develop initially in
a segmental fashion along the anterior–posterior axis. Each arch
has an external covering of ectoderm and an inner covering of
endoderm. Between these epithelial layers are mesenchymal
cells surrounding a pharyngeal arch artery (PAA) (Graham,
2003; Noden and Trainor, 2005). The mesenchymal cells in
PAs are derived from both mesodermal cells and NCCs that
have migrated from the dorsal neural tube. In PAs, NCCs
actively interact with their neighbor cells, and are differen-
tiated into distinct cell types such as vascular smooth muscle
cells, chondrogenic cells, osteogenic cells, neurons, and glial
cells (Noden and Trainor, 2005; Trainor and Krumlauf,
2001).
Accumulated evidence has indicated that TGFβ/BMP sig-
naling in NCCs is critical for their normal development. Neural
crest (NC) disruption of genes encoding receptors of TGFβ/
BMP signaling pathways, including Alk2, 3, 5 and Tgfbr2,
inevitably leads to a spectrum of defects in the craniofacial,
pharyngeal and cardiac regions (Choudhary et al., 2006; Dudas
et al., 2004; Ito et al., 2003; Kaartinen et al., 2004; Stottmann et
al., 2004; Wang et al., 2006) (summarized in Table 1). Smad
proteins are direct mediators of the TGFβ/BMP signaling from
the cell surface to the nucleus. Upon ligand stimulation, TGFβ/
BMP receptor kinase phosphorylates (activates) specific mem-
bers of the receptor activated Smads (R-Smads), which then
oligomerize with the common Smad (co-Smad). The Smad
complex then translocates into the nucleus to regulate expres-Table 1
Targeted genes NCC generation
and migration
Major phenotypes
Alk3 (Stottmann
et al., 2004)
No apparent
defect
Mid-gestation death (E11.5),
shortened OFT with defective
septation, thin-walled ventricle,
reduced proliferation of ventricle
myocardium
Alk2 (Dudas et al.,
2004; Kaartinen
et al., 2004)
Migration
impaired
Cardiac defects: Deficient of smooth
muscle differentiation, persistent
truncus arteriosus (PTA)
Craniofacial defects: cleft palate and
hypotrophic mandible
Alk5 (Wang et al.,
2006)
Not affected Inappropriate remodeling of
pharyngeal arch arteries, abnormal
aortic sac development, failure in
pharyngeal organ migration and
persistent truncus arteriosus,
increased migrated NCC death
Tgf RII (Choudhary
et al., 2006; Ito
et al., 2003)
Not affected Persistent truncus arteriosus PTA,
interrupted aortic arch (IAA-B), cleft
secondary palate, calvaria agenesis
Smad4 (Jia et al.,
2007; Ko et al.,
2007; and this
study)
No apparent
defect
Mid-gestation death (E12.5), thin
wall ventricle, hypoplastic ventricular
septum, normal proliferation rate but
increased apoptosis in PAs, defective
craniofacial and OFT morphogenesission of target genes in coordination with other transcription
factors.
Smad4 is unique among the Smad genes because it encodes
the only co-Smad capable of interacting with both BMP and
TGFβ R-Smads in mammals. Additionally, a germline mutation
in SMAD4 was recently identified in a human patient with
congenital heart disease (Waite and Eng, 2003). It has been well
documented that in addition to the “canonical” pathway of
Smad mediated transcription, TGFβ/BMP signaling may also
transduce signals through non-canonical kinase pathways,
including activation of JNK, p38 MAPK and Erk (Massague
and Gomis, 2006; Moustakas and Heldin, 2005; ten Dijke and
Hill, 2004). Thus, functions of Smad4 in NCCs may not be
simply inferred from “adding up” defects caused by inactivation
of individual TGFβ/BMP receptors in NCCs. Furthermore,
even in certain Smad-mediated responses, Smad4 is not an es-
sential component for activating transcription of target genes
(Chu et al., 2004; He et al., 2006). In this study, we investigated
the specific roles of Smad4 in both NCC development and
morphogenesis of NCC derivatives, with a focus on craniofacial
and OFT development. To overcome the early embryonic
lethality of Smad4 null mice (Chu et al., 2004; Sirard et al.,
2000), we applied a conditional gene inactivation approach to
specifically disrupt Smad4 in NCCs. We show here that NCC
inactivation of Smad4 causes severe abnormalities during cra-
niofacial, PA, OFT and cardiac development, suggesting that
Smad4 plays central roles in mediating TGFβ/BMP signaling
during NCC development.
Materials and methods
Mouse maintenance, genotyping and histological analysis
All procedures are approved by the Institutional Animal Care and Use
Committee at the University of Alabama at Birmingham. Wnt1-Cre mice
(Danielian et al., 1998) (purchased from The Jackson Laboratory) were crossed
with Smad4loxp/loxp mice (Yang et al., 2002) to generate Wnt1-Cre;Smad4loxp/+
male mice, which were crossed with Smad4loxp/loxp female mice to produce
Wnt1-Cre;Smad4loxp/loxp embryos. Mouse genotypes were determined with PCR
analysis using Cre and Smad4 primers as described previously (Yang et al.,
2002). For morphological analysis, all samples were fixed with 4% PFA and
processed into paraffin-embedded sections using routine procedures. For whole
mount staining, the embryos were stored in 100% methanol at −20 °C after PFA
fixation before further processing.
Cardiac ink injection
India ink was injected into the embryo ventricles using a pulled capillary
tube. Injected embryos were subsequently fixed in 4% PFA overnight, dehy-
drated and cleared in benzyl benzoate: benzyl alcohol (1:1).
TUNEL, immunostaining and in situ hybridization analysis
TUNEL staining was performed using DeadEnd Colorimetric TUNEL
System (Promega) following the manufacturer’s protocol. For cell proliferation
analysis, we used an anti-phosphorylated Histone H3 polyclonal antibody
(Upstate) to detect the cells in M phase following procedures described
previously (Song et al., 2007a,b). Whole mount immunostaining for neurofila-
ment was performed using a 2H3 anti-neurofilament monoclonal antibody
(Hybridoma Bank at the Univ. of Iowa). Whole mount and section in situ
hybridization was performed as previously described (Barnes et al., 1994; Song
et al., 2007b).
Fig. 1. Craniofacial defects in Wnt1-Cre;Smad4loxp/loxp embryos. (A–D) Whole mount examination of control and mutant embryos at E11.5 showed that craniofacial and PA development was visibly retarded in the
mutants. Embryos were stained briefly with BM purple and nuclear-fast-red for better visualization. The medial frontonasal prominences failed to expand and join at the midline in the mutant embryo when compared to
the control (indicated with white arrow heads, A, B). The tongue, indicated with white arrows, was evident in the control, but was not observed in the mutant embryo. The fusion between the first and second PAs
(indicated with black arrows) was delayed in the mutant embryo (C vs. D). (E, F) Control and mutant embryos at E11.5 were cross-sectioned and HE stained. The tongue structure (indicated with an arrow) was absent in
the mutant. (G–J) Section in situ hybridization analysis was performed on cross (G, H) and sagittal (I, J) sections of control and mutant embryos (at E11.5) using a MyoD probe. Arrows indicate examples of positively
stained cells. Samples were counterstained with nuclear-fast-red. (K, L) Section in situ hybridization analysis was performed on cross-sections of control and mutant embryos (at E11.5) using a Sox9 probe. The arrows
indicate chondrogenic precursors for Meckel's cartilage. Scale bar: 500 μm. fn: frontonasal process; ls: lingual swelling; man: mandibular process; max: maxillary process; pa: pharyngeal arch; ps: palatal shelf; ton:
tongue; control: Smad4loxp/+; mutant: Wnt1-Cre;Smad4loxp/loxp.
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Fig. 2. Hypoplastic branches of the trigeminal ganglia in Wnt1-Cre;
Smad4loxp/loxp embryos. (A–D) Wholemount immunostaining of neurofilament
using a 2H3 anti-neurofilament monoclonal antibody was performed on control
(A, C) and mutant (B, D) embryos at E10.5. The three branches of trigeminal
(the V cranial) ganglia were hypomorphic in mutant embryos. Scale bar:
500 μm; max.b: maxillary branch; man.b: mandibular branch; op.b: ophthalmic
branch; control: Smad4loxp/+; mutant: Wnt1-Cre;Smad4loxp/loxp.
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Deficiency of Smad4 in NCCs led to mid-gestational lethality
with PA and facial primordium defects
To identify the roles of Smad4 during NCC development, we
specifically disrupted Smad4 in NCCs by crossing Wnt1-Cre;
Smad4loxp/+ mice with Smad4loxp/loxp mice. The number of
mutants (Wnt1-Cre;Smad4loxp/loxp) obtained conformed to the
expected Mendelian ratio until E11.5 (93/351). No live mutant
embryo was recovered beyond E12.5, suggesting that embryo-
nic lethality occurred between E11.5 and E12.5. Many mutant
embryos isolated between E11.5 and E12.0 showed pericardial
edema, dilated heart, and blood pooling in large vessels,
suggesting that embryonic lethality is caused by cardiovascular
insufficiency.
No obvious gross abnormality was found in mutants at E9.5
or E10.5 (data not shown). At E11.5, craniofacial morphogen-
esis was visibly delayed in mutants, although their general body
size appeared normal. The facial prominences (maxillary, man-
dibular, lateral nasal and medial nasal prominences) in mutant
embryos failed to merge, and therefore could not form a com-
plete face at E11.5 (Figs. 1A, B). The underdevelopment was
particularly obvious for the medial nasal prominences; they
failed to expand to the midline. The delay in fusion of left and
right mandibles appeared subtle, but was consistently observed
in all mutants examined at this stage (Figs. 1A, B). The union of
the first and the second PAs in mutants was also delayed
compared to their littermates (Figs. 1C, D).
Embryonic tongue is formed by merging of bilateral lingual
swellings from the mandibular prominences and the tuberculum
impar and contains myoblasts derived from somite mesench-
yme and connective tissues of NCC origin. A complete tongue
was evident in the control embryos at E11.5, but was not seen in
the mutants (Figs. 1A, B, E, F). The secondary palatal shelves,
although budded from the maxillary prominences and normal in
size, grew in a horizontal orientation rather than exhibiting an
initial vertical outgrowth, as seen in normal development (Figs.
1E, F). This altered growth pattern of palatal shelves was likely
secondary to the abnormal development of the tongue, which
usually prevents the palate shelves from horizontal outgrowth
by occupying the oral cavity. In order to determine whether
myogenic and chondrogenic progenitors are present within the
mandibular prominences of mutant embryos, we examined the
myogenic and cartilaginous differentiation markers, MyoD and
Sox9. Section in situ hybridization analysis revealed that ex-
pression of bothMyoD and Sox9was detected in the mandibular
prominences of mutant embryos (Figs. 1G–L). Therefore, we
conclude that although a complete tongue was never formed in
the central oral cavity in the mutant embryos, the primordia of
lingual swellings were present in the medial side of the man-
dibular prominences and failed to expand to the midline.
Next, we examined the development of the cranial and dorsal
root ganglia in mutant embryos (E10.5) via whole mount im-
munostaining with a 2H3 antibody. The three branches of the
trigeminal ganglion (the V cranial ganglion), the ophthalmic,
maxillary and mandibular branches, were hypoplastic in allmutant embryos examined (Fig. 2). We did not observe any
other obvious neural structural defects in mutants from the 2H3
staining study. Therefore, we concluded that expression of
Smad4 in NCCs is essential for normal development of the
trigeminal ganglion.
OFT, ventricle and PAA defects in Wnt1-Cre;Smad4loxp/loxp
embryos
Previous studies have demonstrated that TGFβ/BMP signal-
ing in NCCs is critical for normal development of the OFT and
ventricular myocardial wall (summarized in Table 1). As shown
in Figs. 3A–D, the distal part of the OFT, which had started to
separate into two vessels in control embryos, failed to separate
in mutants (Wnt1-Cre;Smad4loxp/loxp). This phenotype was
more obvious from the side view (Figs. 3C, D). The defect
was further confirmed with section studies (Figs. 3E, F). The
aortic sac was separated into two orifices in control embryos,
while it remained unseparated in mutants. In contrast to the
well-formed OFT cushions in controls, the distal OFT cushions
of mutants were hypoplastic. In addition to the OFT defects,
Wnt1-Cre;Smad4loxp/loxp embryos displayed evident thin-
walled ventricles and hypoplastic ventricular septa (Figs. 3G,
H), suggesting that NCC Smad4 is required for normal deve-
lopment of myocardial wall in mouse embryos.
To determine whether the PAAs were properly patterned in
Wnt1-Cre;Smad4loxp/loxp mice, we performed cardiac India ink
injection experiments. The PAAs were well formed and patent
by E10.5 (Figs. 4A, B), suggesting that disruption of Smad4 in
NCCs does not disrupt initial PAA formation. We further
examined whether the PAAs were correctly remodeled at E11.5.
Results in Figs. 4C, D confirmed our previous observation that
the distal OFT septum was well formed in littermate controls but
Fig. 3. Cardiac and OFT defects in Wnt1-Cre;Smad4loxp/loxp embryos. (A–D) Embryonic hearts (at E11.5) were dissected for whole mount examination. Panels A, B
show the front view; panels C, D show the side view. The OFTof the control embryo began to separate at the distal end, while no septation was observed in the mutant
OFT. This phenotype was more obvious in the side view. Arrows in panels A–D indicate the OFT. (E–H) Embryos at E11.5 were cross-sectioned and HE stained for
histological examination. In the control embryo, the OFT cushions were well formed and the opposing ridges of OFT cushions were beginning to fuse, separating the
OFT into aorta and pulmonary trunk (E). In the mutant embryo, however, the OFT cushions were hypoplastic and the OFT remained a single channel (F). Arrows in
panels E and F indicate OFT cushions. The ventricle wall and ventricular septum of the mutant embryo were hypoplastic compared to those of the control (G vs. H).
Boxed areas were magnified and shown in the upper-right corners. Scale bar: 200 μm. as: aortic sac; la: left atria; lv: left ventricle; ra: right atrial; rv; right ventricle; vs:
ventricular septum; control: Smad4loxp/+; mutant: Wnt1-Cre;Smad4loxp/loxp.
421X. Nie et al. / Developmental Biology 316 (2008) 417–430not in mutant embryos. In control embryos at this stage, PAAs
were in the process of active remodeling. On the left side of
control embryos, the distal ends of the fourth and sixth arteries
were adjoined (Fig. 4E). However, no obvious remodeling was
observed in mutant PAAs (Fig. 4F). A similar retarded remo-deling defect was also observed on PAAs of the right side in
mutant embryos (data not shown). We did not observe abnormal
regression of PAAs at this stage, a defect which was reported in
Wnt1-Cre;Alk2loxp/loxp and Wnt1-Cre;Alk5loxp/loxp embryos
(Kaartinen et al., 2004; Wang et al., 2006).
Fig. 4. Cardiac ink injection analysis. (A, B) India ink injection was performed in control (A) and mutant (B) embryos at E10.5. No obvious defect was observed in
PAA formation in the mutant embryo. (C–F) Control and mutant embryos at E11.5 were injected with India ink. At this stage, the OFTwas dividing in the control OFT
(C), but not in the mutant (D). The fourth and sixth PAAs on the left side of a control embryo (E) were joined at their distal ends; however, this remodeling process was
not observed in the mutant embryo (F). Scale bar: 200 μm. as: aortic sac; lv: left ventricle; oft: outflow tract; pa: pharyngeal arch; paa: pharyngeal arch artery; rv; right
ventricle; control: Smad4loxp/+; mutant: Wnt1-Cre;Smad4loxp/loxp.
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expression of some NCC markers was decreased from the
postmigratory NCCs
Motivated by the discovery that NCC disruption of Smad4
caused severe morphological abnormalities in craniofacial, PA,
and cardiac morphogenesis, we further explored the molecular
pathological defects in mutant embryos. We first examined
expression of different NC markers including Ap-2α, Msx1,
Sox9, and Pax3 in E8.5–9.0 embryos by whole mount in situ
hybridization analysis and did not observe any obvious abnor-
mal expression of these genes (Fig. 5), suggesting that the initial
formation of NC was intact in mutant embryos. This conclusion
is supported by our cell lineage analysis (see below).
We proceeded to evaluate expression of NCC markers in
E9.5 embryos including Msx1, 2, CrabPI, Sox9 and Ap-2α, andour results were consistent with previously published studies
describing their expression patterns (Fig. 6). We observed that
Msx1 and Msx2 were highly expressed in the first and second
PAs, and Sox9 was moderately expressed within the first PAs.
AP-2α was widely expressed in all PAs and NCC migration
streams, while CrabPI was found in the migration streams
adjacent to rhombomere 2, 4, and 6. Therefore, these genes
were expressed with non-identical, yet partially overlapping,
patterns and represented distinct subpopulations of NCCs that
were destined to different developmental fates. Significantly,
the expression of Msx1, -2, Sox9, and Ap-2α were visibly
reduced (but not eliminated) from their expression domains by
NCC knockout of Smad4, whereas expression of CrabPI was
not noticeably affected. To determine whether reduced expres-
sion of some of the NCC markers is due to a reduced number of
NCCs, we performed cell lineage analysis. We crossed Rosa26-
Fig. 5. Normal expression of neural crest markers in Wnt1-Cre;Smad4loxp/loxp
embryos at E8.5. (A–H) Whole mount in situ hybridization analysis was per-
formed on embryos isolated between E8.5 and E9.0 using probes against Ap-2α
(A, B), Msx1 (C, D), Sox9 (E, F) and Pax3 (G, H). No obvious differences were
observed between the control and mutant embryos. The arrows indicate positi-
vely stained areas. Scale bar: 200 μm. control: Smad4loxp/+; mutant: Wnt1-Cre;
Smad4loxp/loxp.
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Smad4loxp/loxp;R26R+/− mice (female), which were then crossed
with Wnt1-Cre;Smad4loxp/+ mice (male) to produce Wnt1-Cre;
Smad4loxp/loxp;R26R+/− embryos. Results from both whole-
mount and section studies showed that comparable amounts of
NCCs are present on their migration paths and in their desti-
nations in control and mutant embryos at E9.5 (Figs. 6K–N),
indicating that generation and migration of NCCs were grossly
normal in mutants.
Altered gene expression in developing PAs and their derivatives
in mutant embryos
To further determine the molecular defects in PAs and their
derivatives caused by NCC disruption of Smad4 at later stages,
we examined expression of multiple genes with in situ hy-bridization assays in embryos from E10.0 to E11.5. In addition
to their early roles in neural crest specification, Msx1 and Msx2
are critical for the development of PAs and their derivatives via
mediating epithelial–mesenchymal interactions. Expression of
bothMsx1 and Msx2 (Figs. 7A–H) was markedly reduced from
the facial primordia of mutant embryos at E10.5. By E11.5,
expression of both genes was absent from the mandibular and
maxillary prominences of the mutants, though their transcripts
were still present in the frontonasal prominences. By contrast,
expression of the two genes in these areas was robust in con-
trols. Pax3 failed to be expressed in the maxillary and man-
dibular prominences of the mutants at both E10.5 and E11.5
stages (Figs. 7I–L).
It has been previously demonstrated that NCCs can regulate
normal developmental processes in neighboring cell popula-
tions in PAs (Noden and Trainor, 2005; Rinon et al., 2007;
Stottmann et al., 2004; Tzahor et al., 2003). To examine whether
NCC disruption of Smad4 also alters gene expression in other
cell populations in PAs, we examined expression of Tbx1, Fgf8
and Shh, which are all known to play critical roles during PA
and OFT morphogenesis. Fgf8 encodes a signaling molecule
expressed in the epithelia of PAs, and is required for normal
growth of PAs and remodeling of OFT (Brown et al., 2004;
Frank et al., 2002; Macatee et al., 2003; Vitelli et al., 2006). We
did not observe obvious defects in expression of Fgf8 in mutant
embryos at E10.5 and E11.0 (Figs. 7M–P). Similar results were
observed for Shh (data not shown). Tbx1 is expressed in non-
NCC derived mesenchymal cells in developing PAs, and plays
critical roles in mediating interactions between NCCs and other
cell populations (Baldini, 2004; Epstein, 2001; Grossfeld, 2003;
Jerome and Papaioannou, 2001; Lindsay et al., 2001; Merscher
et al., 2001; Vitelli et al., 2002a; Yamagishi and Srivastava,
2003; Zhang et al., 2006). Significantly, expression of Tbx1 in
the first and second PAs was noticeably reduced in mutants
(Figs. 7Q, R).
Disruption of Smad4 in NCCs caused massive cell death within
the PAs, but had little effect on their proliferation
To address the potential cellular mechanism underlying the
defects in mutant embryos, we examined cell proliferation and
apoptosis during the development of PAs and facial primordia.
We first examined cell proliferation using an anti-phosphory-
lated Histone H3 antibody (Fig. 8), but did not observe any
apparent reduction in overall proliferation rate in the mutants at
E9.5 (data not shown), E10.5 or E11.5 stages (Fig. 8). We
therefore concluded that the defects in mutant embryos is un-
likely caused by reduced cell proliferation.
We next performed TUNEL analysis on embryos between
E9.5 and E11.5 (the most advanced survival stage of mutants)
with both whole mount and section studies. At E9.5, no increase
in apoptosis was observed in mutant PAs compared to control
samples (data not shown). At E10.5, the littermate controls
exhibited active cell death in the developing PAs (Fig. 9A),
suggesting that apoptosis is normally involved in remodeling of
PAs. We observed massive and aberrant cell death in the facial
primordia and PAs of mutant embryos, most notably in the
Fig. 6. Expression of NCC markers in Wnt1-Cre;Smad4loxp/loxp embryos at E9.5. (A–J) Whole mount in situ hybridization analysis was performed on E9.5
embryos using probes against Msx1 (A, B), Msx2 (C, D), Sox9 (E, F), CrabPI (G, H), and Ap-2α (I, J). The arrows indicate positively stained areas. control:
Smad4loxp/+; mutant: Wnt1-Cre;Smad4loxp/loxp. (K, L) A control (Wnt1-Cre;Smad4loxp/+;R26R+/−) and a mutant (Wnt1-Cre;Smad4loxp/loxp;R26R+/−) embryo at E9.5
were stained with X-gal for whole mount examination. (M, N) X-gal stained control and mutant embryos were cross-sectioned. Scale bar: 500 μm. pa: pharyngeal
arch.
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prominences, and the second arches (Figs. 9A–F). Increased
apoptosis was also seen in mesenchymal cells located between
PA3 and PA6 in mutant embryos (Figs. 9C, D), a region
containing cardiac NCCs (Jiang et al., 2000). Increased
apoptosis in mutants was further confirmed with section studies
at E10.5 (data not shown) and E11.5 (Figs. 9E, F). Aberrant
apoptosis was mainly observed in craniofacial and PA regions,
but not in other regions of mutants. To test if these apoptotic
cells were limited to NCCs, we performed X-gal staining on
Wnt1-Cre;Smad4loxp/loxp;R26R+/− embryos (at E11.0) to label
NCCs and their derivatives followed by the TUNEL assay. As
expected, many NCCs (blue) are positively stained with the
TUNEL signal (brown). Significantly, in addition to NCCs, we
clearly observed non-NCC derived mesenchymal cells that are
also apoptotic (Figs. 9G–I), suggesting that NCC Smad4 is
required for normal survival of both NCC-derived ecto-mesenchyme and mesoderm-derived mesenchyme in PAs of
E11.0 embryos.
Discussion
This study provides compelling mouse genetic evidence de-
monstrating that expression of Smad4 in NCCs is essential for
normal development of NCCs and their derivatives. Depletion
of Smad4 from NCCs causes severe abnormalities in craniofa-
cial, pharyngeal and cardiovascular structures. Furthermore,
compared to the published mouse models, in which genes
encoding TGFβ/BMP receptors were specifically inactivated in
NCCs (Choudhary et al., 2006; Dudas et al., 2004; Ito et al.,
2003; Jia et al., 2007; Kaartinen et al., 2004; Ko et al., 2007;
Stottmann et al., 2004; Wang et al., 2006) (Table 1), Wnt1-Cre;
Smad4loxp/loxp embryos exhibit the most severe embryonic
phenotype, namely early lethality at E11.5. These data strongly
Fig. 7. Altered gene expression in facial primordia and PAs between E10.0 and E11.5 inWnt1-Cre;Smad4loxp/loxp embryos (A–R). Whole amount in situ hybridization
analysis was performed on embryos between E10.0 and E11.5. Expression of both Msx1 (A–D) and Msx2 (E–H) were markedly reduced from developing facial
primordia and PAs of mutant embryos. Pax3 was not expressed in the maxillary and mandibular prominences in E10.5 or E11.5 mutant embryos (I–L). Expression of
Fgf8 appeared to be normal in mutant embryos at E10.0 and E11.0 (M–P). Expression of Tbx1 in the mutant embryo was down-regulated within the mesenchyme of
PAs. (Q, R). Arrows indicate sites of expression. Scale bar: 500 μm. control: Smad4loxp/+; mutant: Wnt1-Cre;Smad4loxp/loxp.
425X. Nie et al. / Developmental Biology 316 (2008) 417–430suggest that Smad4, which encodes the only co-Smad in mam-
mals, plays central roles in mediating TGFβ/BMP signaling
during NCC development.
Our molecular examination of E8.5 embryos suggests that
initial generation and specification of NC occurs normally in
Wnt1-Cre;Smad4loxp/loxp embryos. This conclusion is further
supported by our cell lineage analysis on E9.5 embryos. We
cannot exclude that the lack of abnormality in mutant embryos
at E8.5 is due to incomplete depletion of Smad4 in NCCs. We
began to detect molecular defects in E9.5 mutant embryos,
though no morphological abnormality is obvious at this stage.
Expression of NCC markers including Ap-2α, Sox9, Msx1,-2
was clearly reduced in mutant embryos. Our cell lineage ana-
lysis at E9.5 revealed that comparable amounts of NCCs are
present in their destinations (Fig. 6), and furthermore, we did
not observe any obvious abnormal cell proliferation/apoptosisin mutant embryos at this stage. Therefore, we conclude that the
reduction in expression of these genes is unlikely caused by a
reduced number of NCCs in these areas, but rather, is due to
downregulation of expression of these genes by inactivation of
Smad4. Downregulation ofMsx1, 2 is anticipated because these
two genes are known to be direct downstream targets of BMP
R-Smads (Brugger et al., 2004; Gonzalez et al., 1998). De-
pletion of Smad4 in NCCs is expected to impair transcription
mediated by BMP R-Smads. Regulation of Ap-2α and Sox9
expression by TGFβ/BMP signaling pathways has been re-
ported in several developmental processes (Lincoln et al., 2006;
Luo et al., 2003). It is currently unclear whether the two genes
are also direct downstream targets of Smads. Interestingly, des-
pite the obvious molecular defects in mutants at E9.5, no ob-
vious cellular defect was observed from cell lineage, prolifera-
tion or apoptosis analysis at this stage. It has been previously
Fig. 8. Normal proliferation in Wnt1-Cre;Smad4loxp/loxp embryos. (A–D) Immunohistochemistry assays were performed on cross-sections of a control and a mutant
embryo at E10.5 using an anti-phospho-H3 antibody. No obvious difference was observed between control and mutant samples. Panels C, D correspond to the boxed
areas of panels A, B, respectively. (E, F) Sagittal sections of control and mutant embryos at E10.5 were immunostained with an anti-phospho-H3 antibody. (G–J)
Sagittal sections of a control and a mutant embryo at E11.5 were immunostained with an anti-phospho-H3 antibody. Panels I, J correspond to the boxed regions of
panels G, H, respectively. The size of PA1 in the mutant embryo was clearly reduced. Arrows indicate examples of positively stained cells. Scale bar: 200 μm. control:
Smad4loxp/+; mutant: Wnt1-Cre;Smad4loxp/loxp.
426 X. Nie et al. / Developmental Biology 316 (2008) 417–430reported that cellular defects in NCC migration and survival can
be readily detected in Ap-2α−/− orMsx1−/−;Msx2−/− embryos at
E9.5 (Ishii et al., 2005; Schorle et al., 1996; Zhang et al., 1996).The apparent lag between the molecular defects and the ob-
served cellular defects in Wnt1-Cre;Smad4loxp/loxp embryos can
be explained by the fact that although expression of the markers
Fig. 9. Increased apoptosis in Wnt1-Cre;Smad4loxp/loxp embryos. (A–D) Whole mount TUNEL analysis was performed on control and mutant embryos at E10.5. The control embryo exhibited active cell death in
developing PAs, but most apoptotic cells were located laterally within the facial primordia and PAs. By contrast, the mutant embryo displayed increased cell death in the facial primordia and PAs, notably in the ventral
portion of the mandibular prominences and frontonasal prominences. Massive apoptosis was also seen in cells that were located between PA3 and PA6, where apoptosis was rare in the control. Panels C and D correspond
to the boxed areas of panels A and B, respectively. (E, F) TUNEL analysis was also performed on sections of control and mutant embryos at E11.5. Apoptotic cells were widely distributed in the mutant PAs and facial
primordia, but few in the littermate control. control: Smad4loxp/+; mutant: Wnt1-Cre;Smad4loxp/loxp. (G–I) A control (Wnt1-Cre;Smad4loxp/+;R26R+/−, G) and a mutant (Wnt1-Cre;Smad4loxp/loxp;R26R+/−, H) embryo at
E11.0 was stained with X-gal and cross-sectioned followed by TUNEL analysis. Panel I corresponds to the boxed area of panel H. Black arrows indicate examples of apoptotic cells that were NCCs (blue), while red
arrows indicate examples of apoptotic cells that were non-NCC-derived. Scale bar: 500 μm. ton: tongue.
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428 X. Nie et al. / Developmental Biology 316 (2008) 417–430(Ap-2α, Msx1, 2) is reduced, it is not fully eliminated in NCCs.
The remaining expression of these genes may be sufficient to
support normal growth of NCCs up to E9.5. The reduced ex-
pression of these genes would contribute to the cellular and
morphological defects in mutant embryos at later stages.
Our further molecular characterization of Wnt1-Cre;
Smad4loxp/loxp embryos between E10.0 and E11.5 revealed an
apparent reduction in expression of various genes (including
Msx1, Msx2, Pax3, and Tbx1) from the facial primordia and
developing PAs (Fig. 9). Functions of these genes have been
implicated in mediating interactions between NCCs and their
neighboring cells in facial primordia and PAs, and sub-
sequent organogenesis. Of particular significance, Wnt1-Cre;
Smad4loxp/loxp embryos displayed notably decreased expression
of Tbx1, which is the leading candidate gene for DiGeorge
syndrome and is expressed in non-NCC cells in developing PAs
(Brown et al., 2004; Chapman et al., 1996; Vitelli et al., 2002b).
What has yet to be determined is how Smad4 expressed in
NCCs regulates expression of Tbx1. It has been reported that
altered gene expression in NCCs disturbs expression of Tbx1
and other skeletal muscle markers in PAs, suggesting that NCCs
may secrete certain cytokines to promote myogenic differentia-
tion of mesoderm-derived mesenchyme (Rinon et al., 2007;
Tzahor et al., 2003). Therefore, one possible reason for reduced
expression of Tbx1 is that the elevated NCC apoptosis in Wnt1-
Cre;Smad4loxp/loxp could reduce the amount of cytokines se-
creted from NCCs, and thus lead to a reduction in Tbx1 ex-
pression. It is also worth noting that, in addition to NCCs, we
also observed non-NCC derived mesenchymal cells undergoing
apoptosis at E11.0. Therefore, an alternative explanation, which
does not necessarily exclude the first, is that the reduced ex-
pression of Tbx1 may be merely due to the reduced number of
cells expressing this gene. Inactivation of Tbx1 in mouse em-
bryos caused severe pharyngeal phenotypes including the
hypoplasia of PA2, absence of PA3, 4, 6, abnormal formation
of PAAs, failure in septation of OFT, and others (Arnold et al.,
2006; Jerome and Papaioannou, 2001; Lindsay et al., 2001;
Merscher et al., 2001; Zhang et al., 2006). Reduced expression
of Tbx1would likely contribute to the pharyngeal arch and heart
defects observed in Wnt1-Cre;Smad4loxp/loxp embryos.
One particularly significant discovery from this study is that
elevated apoptosis is also observed in non-NCC derived mesen-
chymal cells by NCC disruption of Smad4. It was previously
demonstrated that NCCs are not required for early cell survival
in PA2. For example, in Hoxa1−/−;Hoxb1−/− 3′RARE−/− em-
bryos (E9.5), which lose NCCs in their second arches, meso-
derm-derived mesenchymal cells can still migrate, proliferate
and survive (Gavalas et al., 2001). Consistent with this report,
we did not observe abnormal proliferation/apoptosis in E9.5
Wnt1-Cre;Smad4loxp/loxp embryos. Our further examination at
later stages provides direct evidence suggesting that the activ-
ities of NCCs are essential for normal survival of mesoderm-
derived mesenchymal cells in PAs at E11.0. Another possible
reason for cell death in PAs is poor circulation caused by the
myocardial wall defect in mutant mice (see below).
Cardiac NCCs normally migrate to the OFT region via the
third, fourth and sixth PAs to form the two-pronged cushions atthe distal portion of the OFT where they contribute to the sep-
tation of aorta and pulmonary outlets (Gittenberger-de Groot
et al., 2005). As expected from NCC survival defects, the
distal portion of the OFT septum failed to form in Wnt1-Cre;
Smad4loxp/loxp embryos, as shown in Fig. 3. The OFT septation
defect appears to be a common feature of all mouse models in
which TGFβ/BMP signaling is impaired in NCCs (Table 1),
indicating that TGFβ/BMP signaling pathways within NCCs
are critical for OFT morphogenesis. However, the defect in OFT
septation is unlikely the primary cause of the embryonic le-
thality at E11.5. Rather, we also observed thin-walled ventricles
caused by NCC disruption of Smad4, similar to that seen in
Wnt1-Cre;Alk3loxp/loxp embryos. It is likely that this abnormal
ventricle development and subsequent inadequate blood supply
are the primary causes of embryonic lethality for both Wnt1-
Cr;Alk3loxp/loxp (Stottmann et al., 2004) and Wnt1-Cre;
Smad4loxp/loxp mice. It was proposed that a small population
of NCC-derived epicardial cells signal through Alk3 to promote
cardiomyocyte proliferation in ventricles (Stottmann et al.,
2004). If this hypothesis is true, our data would suggest that
Smad4 encodes an essential component necessary for NCC-
derived epicardial cells to stimulate ventricular myocardial
growth. In addition to their potential roles in morphogenesis of
ventricles, NCCs may also be required for proper physiological
functions of cardiomyocytes (Conway et al., 1997; Kirby and
Waldo, 1990, 1995). For example, splotch mutant mice, which
are caused by mutation in Pax3 and die by E14.5, display poor
myocardial contractility, a defect which is attributed to defective
cardiac NCCs (Conway et al., 1997). Therefore, our study pro-
vides a valuable mouse model for exploring how NCCs regulate
myocardial wall development.
In summary, our current study, together with two other in-
dependent studies on theWnt1-Cre;Smad4loxp/loxp mouse model
(Jia et al., 2007; Ko et al., 2007), have provided compelling
mouse genetic evidence demonstrating that Smad4 expressed in
NCCs play critical roles for NCC development. Specifically,
disruption of Smad4 in NCCs results in embryonic death at
midgestation with severe morphological defects in the cranio-
facial, pharyngeal, OFT, and cardiac ventricular regions. In-
formation acquired from these studies will help us to understand
the functions of TGFβ/BMP signaling during embryogenesis
and its potential contributions to congenital diseases involving
craniofacial and cardiovascular defects.
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